Douglas M Mccarty
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$8.4MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $8.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 14, 2026 | NIH | SBIR Phase II Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I | $1.5M | NEUROGT INC |
| Sep 14, 2026 | NIH | SBIR Phase II Development of gene therapy product for treating MPS IIIB | $1.3M | NEUROGT INC |
| Sep 16, 2025 | NIH | SBIR Phase II Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I | $1.5M | NEUROGT INC |
| Sep 3, 2025 | NIH | SBIR Phase II Development of gene therapy product for treating MPS IIIB | $1.3M | NEUROGT INC |
| Jul 25, 2025 | NIH | SBIR Phase II Protein depleting pre-existing antibodies for viral gene therapy | $970K | NEUROGT INC |
| Aug 30, 2024 | NIH | SBIR Phase II Development of gene therapy product for treating MPS IIIB | $456K | NEUROGT INC |
| Aug 8, 2024 | NIH | SBIR Phase II Protein depleting pre-existing antibodies for viral gene therapy | $1.0M | NEUROGT INC |
| Jul 27, 2023 | NIH | SBIR Phase II Protein depleting pre-existing antibodies for viral gene therapy | $307K | NEUROGT INC |
Peer ranks
Federal funding#99
Awards as PI#190
Patents#273
Companies
- NEUROGT INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.